Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study’s infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi’omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relative absence of biomarkers for active UC may result both from its generally more benign phenotype (IBDMDB Investigators et al., 2019) and from the smaller number of active UC samples (n = 23) compared with active CD samples (n = 76); as a result, we focused our subsequent analyses on expression differences within the CD subcohort.”
From Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 (2021) · cites this paper as IBDMDB Investigators et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This network of mechanistic associations identified several key components that are central to the alterations seen in IBD, highlighting octanoyl carnitine, several lipids and short-chain fatty acids, the taxa Faecalibacterium, Subdoligranulum, Roseburia, Alistipes, and Escherichia, some at both the metagenomic and metatranscriptomic levels, and host regulators of interleukins49.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multiple lines of evidence point towards central roles of gut microbiome perturbations in the pathogenesis of IBD.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“These studies, which have now reached the first stage of completion49–51, together provide a wealth of information and insights about not only microbial dynamics, but also associated human host responses and microbial inter-relationships.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
In the citing paper
“The authors could then use the 17 top taxa in their ranked list to identify which individuals are dysbiotic, an approach that demonstrated similar or better performance than the GMWI2 or another published metric called the “dysbiotic score”.195”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [195]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Cited by
Items 201–300 of 1,010
Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis
Shao, X., Sun, S., Zhou, Y., Wang, H., Yu, Y., Hu, T., Yao, Y., & Zhou, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.002 · Cited by 144
Commensal consortia decolonize Enterobacteriaceae via ecological control
Furuichi, M., Kawaguchi, T., Pust, M., Yasuma-Mitobe, K., Plichta, D. R., Hasegawa, N., Ohya, T., Bhattarai, S. K., Sasajima, S., Aoto, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-07960-6 · Cited by 155
“We also examined the adult IBD cohort from the Integrative Human Microbiome Project 14 (HMP2) (Extended Data Fig.”
Self-citationPiccinno (2025) · doi:10.1038/s41591-025-03693-9 · Cited by 133
“…for T2D (control n = 882, cases n = 750, four cohorts) 70–73 , ulcerative colitis ( n = 247 and 84), CD ( n = 291 and 83, three cohorts in total) 38,74,75 , inflammatory diseases (including asthma, Behcet syndrome, multiple sclerosis, rheumatoid arthritis and myalgic encephalomyelitis, n = 918…”
Lagoumintzis, G., & Patrinos, G. P. (2023) · Human Genomics · doi:10.1186/s40246-023-00561-w · Cited by 132
Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis
Burgueño, J. F., Fritsch, J., Gonzalez-Horta, E. E., Landau, K. S., Santander, A. M., Fernández, I., Hazime, H., Davies, J. M., Santaolalla, R., Phillips, M. C., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.031 · Cited by 139
Bacteriophage-mediated manipulation of the gut microbiome – promises and presents limitations
Rasmussen, T. S., Koefoed, A. K., Jakobsen, R. R., Deng, L., Castro-Mejía, J. L., Brunse, A., Neve, H., Vogensen, F. K., & Nielsen, D. S. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa020 · Cited by 126
Strati, F., Pujolassos, M., Burrello, C., Giuffrè, M. R., Lattanzi, G., Caprioli, F., Troisi, J., & Facciotti, F. (2021) · Microbiome · doi:10.1186/s40168-020-00991-x · Cited by 146
The role of gut microbiota in T cell immunity and immune mediated disorders
Shim, J. A., Ryu, J. H., Jo, Y., & Hong, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79430 · Cited by 154
“Indeed, enrichment of Klebsiella strains in the fecal of IBD patients than healthy controls has been reported [32].”
ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis
Huang, L., Wang, J., Kong, L., Wang, X., Li, Q., Zhang, L., Shi, J., Duan, J., & Mu, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.247 · Cited by 137
Gut bacterial extracellular vesicles: important players in regulating intestinal microenvironment
Liang, X. H., Dai, N., Sheng, K., Lu, H., Wang, J., Chen, L., & Wang, Y. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2134689 · Cited by 142
L-arginine metabolism as pivotal interface of mutual host–microbe interactions in the gut
Nüse, B., Holland, T., Rauh, M., Gerlach, R. G., & Mattner, J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2222961 · Cited by 141
“Alterations in microbial metabolite pools can even predict IBD types.(22,23) Several mutual interactions between gut microbiota and body tissues also affect the metabolism of L-arg.”
BackgroundKhorsand, B., Aghdaei, H. A., Mojarad, E. N., Nadalian, B., Nadalian, B., & Houri, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1015890 · Cited by 141
“All raw shotgun metagenomics sequencing data were downloaded from NCBI Sequence Read Archive (SRA), under Bioproject accession numbers PRJNA400072 (Franzosa et al., 2019), PRJNA398089 (Lloyd-Price et al., 2019), and PRJNA389280 (Schirmer et al., 2018).”
BackgroundT Cell Responses to the Microbiota
Ivanov, I. I., Tuganbaev, T., Skelly, A. N., & Honda, K. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-011829 · Cited by 124
Arıkan, M., & Muth, T. (2023) · Molecular Omics · doi:10.1039/d3mo00089c · Cited by 150
Mitochondrial function and gastrointestinal diseases
Haque, P. S., Kapur, N., Barrett, T. A., & Theiss, A. L. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00931-2 · Cited by 165
Schaus, S. R., Pereira, G. V., Luis, A. S., Madlambayan, E., Terrapon, N., Ostrowski, M. P., Jin, C., Henrissat, B., Hansson, G. C., & Martens, E. C. (2024) · mBio · doi:10.1128/mbio.00039-24 · Cited by 160
“Given the implication of R. torques as a mucin degrader associated with IBD (31, 35, 39), we aimed to characterize the mechanisms by which R. torques degrades both gastric and colonic mucin and the influence of this degradation on interspecies interactions.”
BackgroundNishijima, S., Stankevič, E., Aasmets, O., Schmidt, T., Nagata, N., Keller, M. I., Ferretti, P., Juel, H. B., Fullam, A., Robbani, S. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.10.022 · Cited by 147
Enhanced cultured diversity of the mouse gut microbiota enables custom-made synthetic communities
Afrizal, A., Jennings, S. A. V., Hitch, T. C. A., Riedel, T., Basic, M., Panyot, A., Treichel, N. S., Hager, F. T., Wong, E. O.-Y., Wolter, B., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.09.011 · Cited by 133
Wu, Y., Zhang, X., Liu, X., Zhao, Z., Tao, S., Xu, Q., Zhao, J., Dai, Z., Zhang, G., Han, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53144-1 · Cited by 156
Byrd, K. M., & Gulati, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.620124 · Cited by 132
Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
Pisani, A., Rausch, P., Bang, C., Ellul, S., Tabone, T., Cordina, C. M., Zahra, G., Franke, A., & Ellul, P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00616-22 · Cited by 150
gutSMASH predicts specialized primary metabolic pathways from the human gut microbiota
Andreu, V., Augustijn, H. E., Chen, L., Zhernakova, A., Fu, J., Fischbach, M. A., Dodd, D., & Medema, M. H. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01675-1 · Cited by 128
Wu, R., Xiong, R., Li, Y., Chen, J., & Yan, R. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103062 · Cited by 126
Henn, M. R., O’Brien, E. J., Diao, L., Feagan, B. G., Sandborn, W. J., Huttenhower, C., Wortman, J. R., McGovern, B. H., Wang-Weigand, S., Lichter, D. I., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.07.048 · Cited by 118
Self-citationGenomic reconstruction of short-chain fatty acid production by the human gut microbiota
Frolova, M. S., Suvorova, I. A., Iablokov, S. N., Petrov, S. N., & Rodionov, D. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.949563 · Cited by 140
“activity (Lloyd-Price et al., 2019); 2) and the German cohort of young children from the TEDDY dataset (Stewart et al.”
BackgroundHaskey, N., Estaki, M., Ye, J., Shim, R. K., Singh, S., Dieleman, L. A., Jacobson, K., & Gibson, D. L. (2023) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjad073 · Cited by 117
“There were no differences between aerobic, anaerobic, facultative anaerobic, and stress-tolerant bacteria [Figure 4].”
BackgroundDysbiotic microbiota interactions in Crohn’s disease
Caparrós, E., Wiest, R., Scharl, M. M., Rogler, G., Gutiérrez, A., Yılmaz, B., Wawrzyniak, M., & Francés, R. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1949096 · Cited by 148
Composition and diverse differences of intestinal microbiota in ulcerative colitis patients
Zhu, S., Han, M., Liu, S., Fan, L., Shi, H., & Li, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.953962 · Cited by 130
Silent recognition of flagellins from human gut commensal bacteria by Toll-like receptor 5
(2023) · doi:10.1126/sciimmunol.abq7001 · Cited by 117
Brewer, R. C., Lanz, T. V., Hale, C. R., Sepich‐Poore, G. D., Martino, C., Swafford, A. D.-E., Carroll, T., Kongpachith, S., Blum, L. K., Elliott, S. E., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq8476 · Cited by 134
“Because the HMP dataset did not use metatranscrip-tomics, we validated the approach by applying this pipeline to a publicly available metatranscriptomic dataset of human stool samples ( 25 ).”
MethodSelf-citationDiversity of Vaginal Microbiome in Pregnancy: Deciphering the Obscurity
Gupta, P., Singh, M. P., & Goyal, K. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00326 · Cited by 115
Álvarez, J., Fernández‐Real, J. M., Guarner, F., Gueimonde, M., Rodríguez, J. M., de Pipaón, M. S., & Sanz, Y. (2021) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2021.01.009 · Cited by 238
Kim, C. Y., Lee, M., Yang, S., Kim, K., Yong, D., Kim, H. R., & Lee, I. (2021) · Genome Medicine · doi:10.1186/s13073-021-00950-7 · Cited by 115
“926, 54, and 26 fecal samples from the USA [44], Cameroon [45], and Luxembourg [46, 47], respectively.”
BackgroundMethodInfluentialFoley, S. E., Tuohy, C. A., Dunford, M., Grey, M. J., Luca, H. E. D., Cawley, C., Szabady, R. L., Maldonado‐Contreras, A., Houghton, J. M., Ward, D. V., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01137-3 · Cited by 129
What Is Metagenomics Teaching Us, and What Is Missed?
New, F. N., & Brito, I. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-012520-072314 · Cited by 134
Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis
Hinrichsen, F., Hamm, J., Westermann, M., Schröder, L., Shima, K., Mishra, N., Walker, A., Sommer, N., Klischies, K., Prasse, D., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.004 · Cited by 114
Genome binning of viral entities from bulk metagenomics data
Johansen, J., Plichta, D. R., Nissen, J. N., Jespersen, M. L., Shah, S. A., Deng, L., Stokholm, J., Bisgaard, H. F., Nielsen, D. S., Sørensen, S. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28581-5 · Cited by 121
Self-citationWang, Y., Zhou, J., Ye, J., Sun, Z., He, Y., Zhao, Y., Ren, S., Zhang, G., Liu, M., Zheng, P., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01635-6 · Cited by 125
“To further explore whether the changes in the gut microbiota of MDD patients were directed towards a healthier state, we estimated a dysbiosis score (DS) for each MDD sample, using HC samples as a reference, and calculated the median value of Bray–Curtis distance between the MDD and HC cohorts [30].”
MethodUnraveling host regulation of gut microbiota through the epigenome–microbiome axis
Pepke, M. L., Hansen, S. B., & Limborg, M. T. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.05.006 · Cited by 122
Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective
Valles-Colomer, M., Menni, C., Berry, S. E., Valdes, A. M., Spector, T. D., & Segata, N. (2023) · Nature Medicine · doi:10.1038/s41591-023-02260-4 · Cited by 114
Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
Qin, L., Liu, N., Bao, C.-L.-M., Yang, D.-Z., Ma, G.-X., Yi, W.-H., Xiao, G.-Z., & Cao, H.-L. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00952-0 · Cited by 114
“Microbial dysbiosis is believed to be a key driving force of the pathogenesis of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis [166].”
BackgroundGut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
Sankarasubramanian, J., Ahmad, R., Avuthu, N., Singh, A. B., & Guda, C. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606298 · Cited by 114
“TheNCBI SRA accession numbers for the four 16S rRNAdatasets are: SRP183770 (10), SRP128892 (11), SRP115494 (12), and ERP008725 (13).”
BackgroundAccurate and sensitive detection of microbial eukaryotes from whole metagenome shotgun sequencing
Lind, A., & Pollard, K. S. (2021) · Microbiome · doi:10.1186/s40168-021-01015-y · Cited by 127
Navigating the complexities of drug development for inflammatory bowel disease
Honap, S., Jairath, V., Danese, S., & Peyrin‐Biroulet, L. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00953-0 · Cited by 138
“…the dysbiosis of the intestinal microbiome in IBD has been the subject of intensive research over the past decade, but as its composition is highly influenced by multiple environmental and non-environmental factors, no reproducible microbial signatures or directed therapies have transpired 28,29 .”
D’Urso, F., & Broccolo, F. (2024) · Applied Sciences · doi:10.3390/app14198627 · Cited by 112
International consensus statement on microbiome testing in clinical practice
Porcari, S., Mullish, B. H., Asnicar, F., Ng, S. C., Zhao, L., Hansen, R., O’Toole, P. W., Raes, J., Hold, G. L., Putignani, L., et al. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00311-x · Cited by 146
Self-citationAhlawat, S., Kumar, P., Mohan, H., Goyal, S., & Sharma, K. K. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1876631 · Cited by 117
Gut microbiota and immunity relevance in eubiosis and dysbiosis
Al-Rashidi, H. E. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.10.068 · Cited by 105
Wang, X., Huang, S., Zhang, M., Su, Y., Pan, Z., Liang, J., Xie, X., Wang, Q., Chen, J., Zhou, L., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115919 · Cited by 120
Metwaly, A., Kriaa, A., Hassani, Z., Carraturo, F., Druart, C., Trebicka, J., Godoy, Y., Schierwagen, R., Bork, P., Iyappan, A., et al. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01041-3 · Cited by 139
Metabolic independence drives gut microbial colonization and resilience in health and disease
Watson, A. R., Füssel, J., Veseli, I., DeLongchamp, J. Z., Silva, M., Trigodet, F., Lolans, K., Shaiber, A., Fogarty, E., Runde, J. M., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02924-x · Cited by 92
“Despite marked changes in gut microbial community composition in IBD [16–18], the microbiota associated with the disease lacks acquired infectious pathogens [19], and microbes that are found in IBD typically also occur in healthy individuals [20], which complicates the search for robust functional or taxonomic markers…”
BackgroundPodlesny, D., Durdevic, M., Paramsothy, S., Kaakoush, N. O., Högenauer, C., Gorkiewicz, G., Walter, J., & Fricke, W. F. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100711 · Cited by 111
Montrose, D. C., Nishiguchi, R., Basu, S., Staab, H. A., Zhou, X. K., Wang, H., Meng, L., Johncilla, M., Cubillos-Ruiz, J. R., Morales, D. K., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.09.008 · Cited by 106
“Moreover, elevated levels of fecal conjugated BAs have been observed in IBD patients.(18,19,21) In fact, it has been suggested that the ability of BAs to disrupt the gut barrier contributes to IBD pathogenesis.”
BackgroundPaneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors
Lu, R., Zhang, Y.-G., Xia, Y., Zhang, J., Kaser, A., Blumberg, R., & Sun, J. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.015 · Cited by 107
Diet–Microbiota Interactions in Inflammatory Bowel Disease
Sugihara, K., & Kamada, N. (2021) · Nutrients · doi:10.3390/nu13051533 · Cited by 120
“3, IBD-associated gut dysbiosis is accompanied by the reduced abundance of butyrate-producing bacteria, such as Roseburia hominis and Faecalibacterium prausnitzii, and, therefore, fecal SCFA levels are lower in IBD patients compared to healthy individuals [61].”
BackgroundInfluentialUnderstanding human health through metatranscriptomics
Ojala, T., Kankuri, E. M., & Kankainen, M. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.02.002 · Cited by 120
Identification of trypsin-degrading commensals in the large intestine
Li, Y., Watanabe, E., Kawashima, Y., Plichta, D. R., Wang, Z., Ujike, M., Ang, Q. Y., Wu, R., Furuichi, M., Takeshita, K., et al. (2022) · Nature · doi:10.1038/s41586-022-05181-3 · Cited by 106
Self-citationMassimino, L., Lamparelli, L. A., Houshyar, Y., D’Alessio, S., Peyrin‐Biroulet, L., Vetrano, S., Danese, S., & Ungaro, F. (2021) · Nature Computational Science · doi:10.1038/s43588-021-00114-y · Cited by 117
Interactions between Nanoparticles and Intestine
Vitulo, M., Gnodi, E., Meneveri, R., & Barisani, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084339 · Cited by 115
Fornelos, N., Franzosa, E. A., Bishai, J., Annand, J. W., Oka, A., Lloyd-Price, J., Arthur, T. D., Garner, A., Avila-Pacheco, J., Haiser, H. J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0655-7 · Cited by 103
Self-citationMICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE
Rodriguez, C., Romero, E., Garrido‐Sánchez, L., Alcaín‐Martínez, G., Andrade, R., Taminiau, B., Daube, G., & García‐Fuentes, E. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1725220 · Cited by 118
“gnavus along with Clostridium hathewayi and Clostridium bolteae have increased expression during dysbiosis, suggesting that they could have a role in the disease.(62) On the other hand, a decrease in the abundance of butyrate-producing, hydrogen-utilizing bacteria and other taxa with anti-inflammatory activity, includ…”
BackgroundSmith, S. A., Ogawa, S. A., Chau, L., Whelan, K. A., Hamilton, K. E., Chen, J., Tan, L., Chen, E. Z., Keilbaugh, S. A., Fogt, F., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133371 · Cited by 112
“Although there are bacterial taxonomic associations with the elevation of fecal acylcarnitines in human IBD, leading to the notion that the gut microbiota might be important for their production (30), our results in germ-free mice showing high levels of fecal acylcarnitines strongly indicates that they are primarily o…”
BackgroundResultInfluentialSelf-citationRapid transcriptional and metabolic adaptation of intestinal microbes to host immune activation
Becattini, S., Sorbara, M. T., Kim, S. G., Littmann, E. R., Dong, Q., Walsh, G., Wright, R. J., Amoretti, L. A., Fontana, E., Hohl, T. M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.01.003 · Cited by 109
Álvarez, J., Fernández‐Real, J. M., Guarner, F., Gueimonde, M., Rodríguez, J. M., de Pipaón, M. S., & Sanz, Y. (2021) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.01.002 · Cited by 153
Bao, C., Wu, L., Wang, D., Chen, L., Jin, X., Shi, Y., Li, G., Zhang, J., Zeng, X., Chen, J., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101300 · Cited by 107
Mohamed, A. R., Ochsenkühn, M. A., Kazlak, A. M., Moustafa, A., & Amin, S. A. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad005 · Cited by 125
“This holistic approach has been recently applied to study the plant microbiome (Zolti et al. 2020; for a review, see Xu et al. 2021b), the human microbiome (HeintzBuschart et al. 2016, Lloyd-Price et al. 2019, Park et al. 2022) [for a review, see Zhang et al. (2019)].”
BackgroundMethodVila, A. V., Zhang, J., Liu, M., Faber, K. N., & Weersma, R. K. (2024) · Gut · doi:10.1136/gutjnl-2023-329969 · Cited by 123
“4 10 Despite the apparent involvement of the gut microbiota in the pathology of IBD, the mechanisms”
Yang, S.-Y., Han, S. M., Lee, J., Kim, K. S., Lee, J. E., & Lee, D. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2412.12001 · Cited by 139
“For instance, integrative studies have identified microbial biomarkers for diseases such as T2D and IBD, demonstrating how genetic, environmental, and dietary factors influence disease pathogenesis [21, 167].”
Gut microbial DL-endopeptidase alleviates Crohn’s disease via the NOD2 pathway
Gao, J., Zhao, X., Hu, S., Huang, Z., Hu, M., Jin, S., Lu, B., Sun, K., Wang, Z., Fu, J., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.08.002 · Cited by 113
Kim, S., Park, S., Hwang, S.-H., Lee, E.-Y., Kim, J.-H., Lee, G. S., Lee, G., Chang, D., Lee, J. G., Hwang, J., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.05.007 · Cited by 120
Shukla, V., Singh, S., Verma, S., Verma, S., Rizvi, A. A., & Abbas, M. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.08.005 · Cited by 133
Bile acids activated receptors in inflammatory bowel disease
Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S. (2021) · Cells · doi:10.3390/cells10061281 · Cited by 103
Alterations of the Gut Microbiome Composition and Lipid Metabolic Profile in Radiation Enteritis
Li, Y., Yan, H., Zhang, Y., Li, Q., Yu, L., Li, Q., Liu, C., Xie, Y., Chen, K., Ye, F., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.541178 · Cited by 104
“Recent years, it is well established that gut microbiome and their metabolites can widely regulate host metabolism, but the interactions of the molecular interface among them are highly dynamic and complex, which are still less well understood (Saw et al., 2017; McGrail et al., 2018; Lloyd-Price et al., 2019).”
BackgroundEilam, Y., Khattib, H., Pintel, N., & Avni, D. (2023) · Global Challenges · doi:10.1002/gch2.202200177 · Cited by 101
Nguyen, L. H., Cao, Y., Hur, J., Mehta, R. S., Sikavi, D. R., Wang, Y., Ma, W., Wu, K., Song, M., Giovannucci, E. L., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.008 · Cited by 119
Self-citationFood Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis
Raoul, P. C., Cintoni, M., Palombaro, M., Basso, L., Rinninella, E., Gasbarrini, A., & Mele, M. C. (2022) · Microorganisms · doi:10.3390/microorganisms10010167 · Cited by 129
Yang, K., Wang, X., Huang, R., Wang, H., Lan, P., & Zhao, Y. (2022) · Advanced Science · doi:10.1002/advs.202104089 · Cited by 115
The future is now? Clinical and translational aspects of “Omics” technologies
D’Adamo, G. L., Widdop, J. T., & Giles, E. M. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12404 · Cited by 110
Critical roles of bile acids in regulating intestinal mucosal immune responses
Sun, R., Xu, C., Feng, B., Gao, X., & Liu, Z. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211018098 · Cited by 118
Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease
Tomofuji, Y., Kishikawa, T., Maeda, Y., Ogawa, K., Nii, T., Okuno, T., Oguro-Igashira, E., Kinoshita, M., Yamamoto, K., Sonehara, K., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221267 · Cited by 108
Discovery of bioactive microbial gene products in inflammatory bowel disease
Zhang, Y., Bhosle, A., Bae, S., McIver, L. J., Pishchany, G., Accorsi, E. K., Thompson, K. N., Arze, C., Wang, Y., Subramanian, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04648-7 · Cited by 100
Self-citationLiu, Q., Li, B., Li, Y., Wei, Y., Huang, B., Liang, J., You, Z., Li, Y., Qian, Q., Wang, R., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323565 · Cited by 110
Fitzgerald, K. C., Smith, M. D., Kim, S., Sotirchos, E. S., Kornberg, M. D., Douglas, M., Nourbakhsh, B., Graves, J., Rattan, R., Poisson, L., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100424 · Cited by 111
“We also found lower levels of expression for HCA3-network genes in PwMS; however, this difference was not statistically significant (p = 0.11; Figure 3C; Data S1M).”
BackgroundMethodInfluentialSinha, A., Li, Y., Mirzaei, M. K., Shamash, M., Samadfam, R., King, I. L., & Maurice, C. F. (2022) · Microbiome · doi:10.1186/s40168-022-01275-2 · Cited by 108
He, R., Li, P., Wang, J., Cui, B., Zhang, F., & Zhao, F. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2100197 · Cited by 98
Dei‐Cas, I., Giliberto, F., Luce, L. N., Dopazo, H., & Steinhardt, A. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-69537-3 · Cited by 109
Keshteli, A. H., Valcheva, R. S., Nickurak, C., Park, H., Mandal, R., van Diepen, K., Kroeker, K. I., van Zanten, S., Halloran, B. P., Wishart, D. S., et al. (2022) · Nutrients · doi:10.3390/nu14163294 · Cited by 110
“7% of taxonomic variation longitudinally in IBD patients [42].”
BackgroundAltered Skin and Gut Microbiome in Hidradenitis Suppurativa
McCarthy, S., Barrett, M., Kirthi, S., Pellanda, P., Vlckova, K., Tobin, A.-M., Murphy, M., Shanahan, F., & O’Toole, P. W. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.05.036 · Cited by 98
Pareek, S., Kurakawa, T., Das, B., Motooka, D., Nakaya, S., Rongsen‐Chandola, T., Goyal, N. P., Kayama, H., Dodd, D., Okumura, R., et al. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0110-9 · Cited by 99
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
Lee, J.-Y., Hall, J. A., Kroehling, L., Wu, L., Najar, T., Nguyen, H. H., Lin, W.-Y., Yeung, S. T., Silva, H. M., Li, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.12.008 · Cited by 95
Prebiotic and Probiotic Modulation of the Microbiota–Gut–Brain Axis in Depression
Radford-Smith, D. E., & Anthony, D. C. (2023) · Nutrients · doi:10.3390/nu15081880 · Cited by 96
Long, Y., Luo, J., Zhang, Y., & Xia, Y. C. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa146 · Cited by 108
Statistical challenges in longitudinal microbiome data analysis
Kodikara, S., Ellul, S., & Cao, K. L. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac273 · Cited by 111
“The role of the microbiome in biological systems and in disease has been broadly explored [45, 53, 65], but is still lacking a thorough understanding of its structure and function [21].”
BackgroundRoseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease
Shen, Z., Luo, W., Tan, B., Nie, K., Deng, M., Wu, S., Xiao, M., Wu, X., Meng, X., Tong, T., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104285 · Cited by 106
Flannigan, K. L., Nieves, K., Szczepanski, H. E., Serra, A., Lee, J. W., Alston, L. A., Ramay, H. R., Mani, S., & Hirota, S. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.014 · Cited by 106
“To do this, we reanalyzed the fecal metabolome dataset from non-IBD and IBD patients from 5 different academic hospitals across the United States that were profiled (via liquid chromatography with tandem mass spectrometry) as part of the Human Microbiome Project 2.(44) When compared with fecal samples from non-IBD con…”
MethodMetabolome–Microbiome Crosstalk and Human Disease
Lee‐Sarwar, K. A., Lasky-Su, J. A., Kelly, R. S., Litonjua, A. A., & Weiss, S. T. (2020) · Metabolites · doi:10.3390/metabo10050181 · Cited by 109
“In iHMP analyses of inflammatory bowel disease (IBD), fecal metabolites, and metabolic pathways were associated with IBD, including bile acids, short-chain fatty acids, sphingolipids, acylcarnitines, triacylglycerols, and tetrapyrroles [56,57].”
BackgroundA biosynthetic pathway for the selective sulfonation of steroidal metabolites by human gut bacteria
Yao, L., D’Agostino, G. D., Park, J., Hang, S., Adhikari, A. A., Zhang, Y., Li, W., Ávila-Pacheco, J., Bae, S., Clish, C. B., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01176-y · Cited by 106
Self-citationThe emerging role of the small intestinal microbiota in human health and disease
Ruigrok, R. A. A. A., Weersma, R. K., & Vich Vila, A. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201155 · Cited by 91
“SCFAs, for example, increase antimicrobial peptide and mucus production and stimulate maturation and expansion of colonic regulatory T cells to reduce local inflammatory responses.(83,85) Studies implicating SI microbes, specifically, are also emerging.”
BackgroundAirway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease
Liang, W., Yang, Y., Gong, S., Wei, M., Ma, Y., Feng, R., Gao, J., Liu, X., Tu, F., Ma, W., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.04.018 · Cited by 107
Kim, E. S., Tarassishin, L., Eisele, C. D., Barré, A., Nair, N. K., Rendon, A. P., Hawkins, K. A., Debebe, A., White, S. R., Thjømøe, A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.050 · Cited by 100
Metadata
- Authors
- Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., Rahnavard, G., Sauk, J., Shungin, D., Vázquez-Baeza, Y., White, R. A., IBDMDB Investigators, Bishai, J., Bullock, K., Deik, A., Dennis, C., Kaplan, J. L., Khalili, H., McIver, L. J., Moran, C. J., Nguyen, L., Pierce, K. A., Schwager, R., Sirota-Madi, A., Stevens, B. W., Tan, W., ten Hoeve, J. J., Weingart, G., Wilson, R. G., Yajnik, V., Braun, J., Denson, L. A., Jansson, J. K., Knight, R., Kugathasan, S., McGovern, D. P. B., Petrosino, J. F., Stappenbeck, T. S., Winter, H. S., Clish, C. B., Franzosa, E. A., Vlamakis, H., Xavier, R. J., & Huttenhower, C.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- Pacific Northwest National Laboratory (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- University of California San Diego (US)
- Washington University in St. Louis (US)
- Corresponding author
- Huttenhower, Curtis
- ORCID
- Arze, Cesar
- Ananthakrishnan, Ashwin N.
- Schirmer, Melanie
- Ajami, Nadim J.
- Bonham, Kevin S.
- Brislawn, Colin J.
- Casero, David
- Graeber, Thomas G.
- Hall, A. Brantley
- Mallick, Himel
- Plichta, Damian R.
- Sauk, Jenny
- Shungin, Dmitry
- Bullock, Kevin
- Deik, Amy
- Khalili, Hamed
- McIver, Lauren J.
- Nguyen, Long
- Pierce, Kerry A.
- Yajnik, Vijay
- Knight, Rob
- McGovern, Dermot P. B.
- Winter, Harland S.
- Clish, Clary B.
- Franzosa, Eric A.
- Vlamakis, Hera
- Xavier, Ramnik J.
- Huttenhower, Curtis
- Venue
- Nature
- Published
- 2019-05-29
- Volume
- 569
- Issue
- 7758
- Pages
- 655-662
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6650278
- OpenAlex
- W2947189704
- Cited by
- 3,143
- References
- 101
- Citations by year
- 2026: 500 · 2025: 555 · 2024: 498 · 2023: 402 · 2022: 441 · 2021: 452 · 2020: 247 · 2019: 42
- FWCI
- 98.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1053486, DEAC05–76RL01830, 76RL01830)
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?)
- Battelle (AC05-76RL01830, DE- AC05-76RL01830, DE-AC05)
- Leona M. and Harry B. Helmsley Charitable Trust (P01DK046763, U01DK062413)
- Harvard T.H. Chan School of Public Health
- Crohn's and Colitis Foundation (563526)
- Broad Institute
- Vetenskapsrådet (4.1-2016-00416)
- National Institutes of Health (DBI-1053486, UL1TR001881, DE-AC05-76RL01830)
- National Human Genome Research Institute (R01HG005969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, R24DK110499, U54DK102557, U01DK062413, P30DK078392, P30DK043351, P30DK040561)
- National Institute of Dental and Craniofacial Research (U54DE023798)
- National Center for Advancing Translational Sciences
- Army Research Office (W911NF-11-1-0473, W911NF, W911NF-11)
- Pacific Northwest National Laboratory (DEAC0576RL01830, 76RL01830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut microbiota, dysbiosis, multi-omics, facultative anaerobes, obligate anaerobes, Clostridia, acylcarnitines, bile acids, short-chain fatty acids, serum antibodies, disease activity, temporal variation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fungi, Health, Humans, Phylogeny, Species Specificity, Viruses, Inflammatory Bowel Diseases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.